|
PLEASE NOTE:
Online
presentations from the Thimerosal and Neurodevelopmental Outcomes meeting are
subject to copyright protection. Permission from the speaker is required
prior to any copying, reproducing, or rebroadcasting any portion of the
speaker's presentations. Additional copyright and legal policies of The
National Academies can be read here.
For best results, use
Internet Explorer to view slides. The audiocast segments require RealPlayer.
Click here to download RealPlayer 8 Basic
for free.
Due to the poor sound
quality of some presentations, the meeting
transcript has been made available in PDF file.
Thimerosal-Containing
Vaccines and
Neurodevelopmental Outcomes
Meeting Agenda
Cambridge, MA
Monday, July 16, 2001
Welcome
and Introductions
Marie McCormick, MD, ScD
Chair, Immunization Safety
Review Committee
Risk Assessment of
Thimerosal in Childhood Vaccines
Leslie K. Ball, MD
Division of Vaccines and
Related Product Applications
Office of Vaccines Research
and Review
Center for Biologics
Evaluation and Research
Food and Drug Administration
History of Thimerosal
Concern and Comparative Policy Actions
Gary L. Freed, MD
The Percy and Mary Murphy
Professor of Pediatrics and Child Health Delivery
Director, Division of
General Pediatrics
Professor of Health
Management and Policy
University of Michigan
Margie Andreae, MD
Associate Director for
Clinical Services
Division of General
Pediatrics
University of Michigan
Biologic Plausibility and
Planned Research
Jane M. El-Dahr, MD
Head, Section of Pediatric
Allergy, Immunology, Rheumatology
Tulane University Health
Sciences Center
<>
David S. Baskin, MD
Professor of Neurosurgery
Baylor College of Medicine
The Role of Heavy Metals in Autism
Jeffrey Bradstreet, MD
Director of Research
The International Autism Research Center
<>
Pharmacokinetic Modeling of Hair Mercury Levels from Thimerosal
David Brown, ScD
Toxicologist and Independent Consultant
Connecticut
Vaccine Safety Datalink (VSD) Screening Study and Follow-up Analysis with
Harvard Pilgrim Data
Thomas Verstraeten, MD, MSc
EIS Officer, National Immunization Program
Centers for Disease Control and Prevention
Protocol for National Immunization Program Study on Thimerosal
Paul Stehr-Green, DrPH, MPH
Associate Professor of Epidemiology
University of Washington School of Community Medicine and Public Health
William Thompson, PhD (for Q&A period only)
Epidemiologist, National Immunization Program
Centers for Disease Control and Prevention
Seychelles Islands Study
Gary Myers, MD
Professor of Neurology and Pediatrics
University of Rochester School of Medicine and Dentistry
Faroe Islands Study
Philippe Grandjean, MD, DMSc
Institute of Community Health
Odense University, Denmark
In Vitro Studies of Thimerosal Toxicity
Boyd E. Haley, PhD
Chairman and Professor, Department of Chemistry
University of Kentucky
Comparative Toxicology of Ethyl and Methyl Mercury
George Lucier, PhD
Former Director, Environmental Toxicology Program
National Institute for Environmental Health Sciences
Rising Incidence of Autism: Association with Thimerosal
Mark F. Blaxill, MBA
Autism Society of America, Massachusetts Chapter
NIH Studies on Thimerosal
Polly Sager, PhD
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Wrap-up Commentary on Thimerosal Risk
From the Perspective of a Developmental Toxicologist
George Lambert, MD
Environmental and Occupational Health Sciences Institute
Robert Wood Johnson Medical School
·
Slides
·
Audio
Presentation
Wrap-up Commentary on Thimerosal Risk from the Perspective of a Pediatric
Vaccinologist
Neal Halsey, MD
Professor and Director
Division of Disease Control
Department of International Health
Johns Hopkins University
o
Slides
o
Audio
Presentation
Public comments
§
Audiocast
Return to
Thimerosal and Neurodevelopmental Outcomes page
|
